tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Quantum BioPharma receives final reports for two studies of Lucid-21-302
PremiumThe FlyQuantum BioPharma receives final reports for two studies of Lucid-21-302
10d ago
Quantum BioPharma Strengthens MS Program with New Clinical Advisor
Premium
Company Announcements
Quantum BioPharma Strengthens MS Program with New Clinical Advisor
11d ago
Quantum BioPharma appoints Jack Antel as clinical development advisor
Premium
The Fly
Quantum BioPharma appoints Jack Antel as clinical development advisor
11d ago
Quantum Group announces Health Canada granted Product License for Qlarity
PremiumThe FlyQuantum Group announces Health Canada granted Product License for Qlarity
24d ago
Quantum BioPharma’s Licensee Unbuzzd Wellness to Host Investor Webinar on Innovative Hangover Solution
Premium
Company Announcements
Quantum BioPharma’s Licensee Unbuzzd Wellness to Host Investor Webinar on Innovative Hangover Solution
30d ago
Quantum BioPharma Receives BUY Rating from Kingswood Capital Partners
Premium
Company Announcements
Quantum BioPharma Receives BUY Rating from Kingswood Capital Partners
1M ago
Quantum signs agreement with CDMO to manufacture oral Lucid-21-302
PremiumThe FlyQuantum signs agreement with CDMO to manufacture oral Lucid-21-302
2M ago
Quantum BioPharma Reports Promising PET Tracer Results for MS
Premium
Company Announcements
Quantum BioPharma Reports Promising PET Tracer Results for MS
2M ago
Quantum BioPharma announces results from study on PET tracer
Premium
The Fly
Quantum BioPharma announces results from study on PET tracer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100